Table 2. Subjects’ outcomes between the two groups ().
| Group | Standard group (n=74) | HFNC group (n=77) | t/χ2/U | P |
|---|---|---|---|---|
| NIV treatment duration (days) | 5.93±4.02 | 4.22±2.12 | −3.253 | 0.002 |
| Length of stay in the ICU (days) | 9.89±6.87 | 10.34±11.27 | −0.292 | 0.771 |
| Total length of hospital stay (days) | 18.41±14.42 | 20.27±18.73 | −0.679 | 0.498 |
| Invasive ventilation duration (days) | 2.70±5.97 | 2.35±10.74 | 0.247 | 0.805 |
| Hospitalization expenses (yuan) | 92,867.76±83,518.55 | 91,848.42±95,841.43 | 0.066 | 0.947 |
| ROX index | 3.79±0.41 | 4.63±0.59 | 10.190 | <0.001 |
| VAS | 3.24±0.48 | 5.67±0.83 | 21.910 | <0.001 |
HFNC, high-flow nasal cannula; NIV, non-invasive ventilation; ICU, intensive care unit; ROX, rate-oxygenation index; VAS, visual analogue scale.